Naruse et al.68 reported that plasma aldosterone concentration was significantly decreased during the first 4 weeks of ARB administration, but aldosterone breakthrough occurred after 8 weeks with an increase of serum Ang II concentration in stroke-prone spontaneously hypertensive rats. Here, AGT is linked to stroke disorder.